Advanced Physiological Response Systems
Legal Citation
Summary of the Inventive Concept
The Advanced Physiological Response Systems leverage the core technology of implantable drug delivery devices to monitor and respond to various physiological reactions, addressing previously unmet needs in environmental pollution, athletic injuries, anxiety disorders, and allergic reactions.
Background and Problem Solved
The original patent focused on drug delivery devices for treating opioid overdoses. However, the limitations of this approach lie in its narrow application scope. The Advanced Physiological Response Systems expand this technology to tackle a broader range of health concerns, providing a more comprehensive solution for monitoring and responding to physiological reactions.
Detailed Description of the Inventive Concept
The Advanced Physiological Response Systems comprise implantable sensors capable of detecting changes in body temperature and other physiological reactions indicative of exposure to toxic substances, injuries, allergic reactions, or anxiety disorders. These sensors trigger the release of a counteracting agent, such as a cooling agent, pain-relieving agent, or calming agent, from an integrated drug delivery device. This real-time response enables prompt treatment and prevention of further damage to the body.
Novelty and Inventive Step
The new claims introduce a novel application of the original patent's technology, shifting the focus from opioid overdoses to a diverse range of health concerns. The inventive step lies in the integration of sensors and drug delivery devices to create a holistic response system, which is not obvious from the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include wearable devices, external sensors, or non-invasive monitoring methods. Variations could involve different types of counteracting agents, tailored to specific physiological reactions or health conditions.
Potential Commercial Applications and Market
The Advanced Physiological Response Systems have vast commercial potential in industries such as environmental monitoring, sports medicine, mental health, and allergy treatment. The market demand for such systems is substantial, driven by the growing need for proactive and personalized healthcare solutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M5/14276 |
| A | A61 | A61B5/4839 |
| A | A61 | A61B5/4845 |
| A | A61 | A61B5/4848 |
| A | A61 | A61K9/0024 |
| A | A61 | A61K9/0097 |
| A | A61 | A61M5/44 |
| A | A61 | A61M31/002 |
| A | A61 | A61M37/0069 |
| A | A61 | A61B5/01 |
| A | A61 | A61F2250/0068 |
| A | A61 | A61K31/485 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technology, specifically implantable drug delivery systems and physiological monitoring devices, encompassing biomedical sensors, drug release mechanisms, and adaptive medical response technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in implantable sensors, drug delivery systems, and physiological monitoring, possessing knowledge of materials science, biocompatible polymers, and adaptive medical technologies
Obviousness Rationale
A PHOSITA would recognize that the core technological framework of the source patent's implantable drug delivery device can be readily adapted to multiple physiological response scenarios by substituting detection mechanisms, trigger conditions, and drug payloads. The fundamental design principles of sensor-triggered drug release remain consistent across different medical applications, making the PTD's variations predictable extensions of the original patent's core technology.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,758 |
|---|---|
| Title | Drug delivery device and method |
| Assignee(s) | Purdue Research Foundation |